German Pharmacovigilance Day

The German Pharmacovigilance Day returns to Frankfurt to look at evolving topics in pharmacovigilance. Although we are governed by one EU framework, there is enough space for interpretation depending on countries, the type of products one manages and new challenges arising, We are looking at a wide range of topics such as:

• Social media and PV - Hurdles and solutions for mid-size pharma companies
• Weight loss drugs – the new blockbusters and their emerging safety profile
• Risk minimization measures
• Swissmedic - How to deal with the new ICSR reporting requirements related to risk assessment
• Pharmacovigilance and pregnancies - what to do if the patient cannot just stop taking the drug
• Pharmacovigilance across borders – Sharing experience
• Artificial Intelligence – the emerging picture for regulation in pharmacovigilance

The German Pharmacovigilance Day provides an opportunity for professionals to come together, exchange knowledge and experiences, and explore innovative solutions to the challenges faced in pharmacovigilance. By sharing insights and discussing potential solutions, we can collectively advance the field of pharmacovigilance and ensure the safety and well-being of patients.

Conference language: ENGLISH

The Scientific Committee:

Marc Zittartz, Principal Consultant and Managing Director, Insife Germany
Carsten Wieser, Head Global Safety, Dr Falk Pharma

Who should attend?

The conference program is designed for healthcare professionals or pharmacists working in the pharmacovigilance units in the pharmaceutical industry or regulatory agencies, either as specialists or managers, QPPVs, inspectors and QA personnel including auditors, employees in regulatory affairs units with close relations to pharmacovigilance, vendors and CROs working with patient safety data.